FDA Drug Approvals for Cancer in 2014

Expanding and Advancing the Future of Renal Cell Carcinoma Treatment

Support for the recommendation is based on phase 3 ADRIATIC trial results showing a 27% reduction in the risk of death with durvalumab vs placebo.

Eric Jonasch, MD

Integrative Oncology Approaches to Managing Gastrointestinal Cancer

Eric Jonasch, MD, believes that the Kidney Cancer Research Consortium may broaden their reach to provide care to many different groups of patients.

Ariana Pelosci

Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology

Options like acupuncture or cannabis use may be viable to help manage symptoms related to gastrointestinal cancer treatment.

Shwetal Mehta, PhD

January 27th 2025

Best Practices for Boosting the Enrollment of Underserved Populations in Cancer Clinical Trials

Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.

Coral Omene, MD, PhD;Mariam Eskander, MD, MPH

FDA OKs T-DXd Companion Diagnostic in HER2-Low Metastatic Breast Cancer

Coral Omene, MD, PhD, and Mariam Eskander, MD, MPH, discuss how to continue engagement in clinical trial enrollment for underserved populations.

The PATHWAY HER2 test has been approved to identify patients with HER2-ultralow metastatic breast cancer who may benefit from treatment with T-DXd.

CHMP Recommends EU Approval for Durvalumab in Limited-Stage SCLC

The PATHWAY HER2 test has been approved to identify patients with HER2-ultralow metastatic breast cancer who may benefit from treatment with T-DXd.

Related Content

Expanding and Advancing the Future of Renal Cell Carcinoma Treatment

Support for the recommendation is based on phase 3 ADRIATIC trial results showing a 27% reduction in the risk of death with durvalumab vs placebo.

Eric Jonasch, MD

Integrative Oncology Approaches to Managing Gastrointestinal Cancer

Eric Jonasch, MD, believes that the Kidney Cancer Research Consortium may broaden their reach to provide care to many different groups of patients.

Ariana Pelosci

Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology

Options like acupuncture or cannabis use may be viable to help manage symptoms related to gastrointestinal cancer treatment.

Shwetal Mehta, PhD

January 27th 2025

Best Practices for Boosting the Enrollment of Underserved Populations in Cancer Clinical Trials

Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.

Coral Omene, MD, PhD;Mariam Eskander, MD, MPH

FDA OKs T-DXd Companion Diagnostic in HER2-Low Metastatic Breast Cancer

Coral Omene, MD, PhD, and Mariam Eskander, MD, MPH, discuss how to continue engagement in clinical trial enrollment for underserved populations.